Trial intelligence / Profile preview

Zoloft in advanced cancer symptoms and survival trial

ISRCTN72466475Phase 3Completed

Sponsor
NHMRC Clinical Trials Centre
Start
May 2002
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of sertraline in cancer, sponsored by NHMRC Clinical Trials Centre. Started May 2002; status: completed.

02

Drugs

sertraline
03

Conditions

cancer

Beyond the preview

Go deeper on ISRCTN72466475.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN72466475.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call